Your browser doesn't support javascript.
loading
Hepatitis B virus and hepatocellular carcinoma: antiviral therapy and risk estimation / 国际外科学杂志
International Journal of Surgery ; (12): 846-848, 2012.
Article in Chinese | WPRIM | ID: wpr-429822
ABSTRACT
The incidence of hepatocellular carcinoma is increasing year by year all over the world.Hepatoma has become one of the main causes of cancer-related death.For many years,studies found the chronic hepatitis B virus infection is the leading cause of hepatocellular carcinoma,and antiviral therapy for hepatitis B virus could obviously reduce the incidence of hepatoma and prevent recurrence after hepatectomy.Making appropriate risk estimation in patients with chronic hepatitis B and providing patients with high risk the effective medical intervention can help to prevent the occurrence and delay the development of hepatocellular carcinoma.

Full text: Available Index: WPRIM (Western Pacific) Type of study: Etiology study Language: Chinese Journal: International Journal of Surgery Year: 2012 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Type of study: Etiology study Language: Chinese Journal: International Journal of Surgery Year: 2012 Type: Article